gretel
18 Sep 2015
Another bargain acquisition today.... ...that's 2 in 3 days.....[link] a max $14m (25% in performance-related shares) for $2.2m EBITDA sounds like a bargain to me. And CHT say it will be immediately earnings-enhancing. Plus there'll be considerable savings from cost synergies etc.Forecasts will have to be raised again.
gretel
16 Sep 2015
Big earnings-enhancing acquisition Big acquisition today for this off-the-radar stock:[link] acquisition, of which $11.5m in cash and the balance in shares dependent on meeting financial targets - so nicely played by CHT.Not only earnings-enhancing, but also further synergies to come - and it already makes $1.9m historic EBITDA.Finncap retain their 280p target and conclude as follows: "Constellation has progressed its strategy of building a major provider of US medical billings services with the acquisition of NorthStar First Health at a maximum total cost of $18m. This represents an EV/EBITDA of 9.5x, potentially falling to 4.0x when targeted cost savings have been achieved. We will reassess our forecasts with the soon to be announced interims, but expect this acquisition to enhance FY 2016E EPS by c5% and FY 2017E by c10%."
techno stock
03 Jul 2015
What's happennig with trades? Has anybody tried to buy or sell these, no trades going thru and Barclays couldn't accept deals at the week end - Anybody know why?
gretel
03 Jun 2015
280p target price - 71% upside Good, solid trading update today - in particular it's encouraging that PPP has been integrated so well already.No doubt we'll see more acquisitions soon.Finncap retain their 280p target price today - that's 71% upside from today's starting 164p price:"Constellation Healthcare*: On track for strong growth (CORP)Constellation has confirmed that trading is in line with expectations and we are maintaining our forecast of 43% EPS growth for this year. The group is performing well across all divisions and PPP, acquired in March, is already proving a success and has integrated well. Organic contract wins continue, with 14 new clients added in the year to date that are estimated to deliver $8.5m sales and $3m EBITA in a full year. This is up from the $6-7m sales and $2-3m EBITA highlighted in April. With financing in place, post the recent placing, to progress the acquisitions strategy that we expect to be significantly enhancing, we maintain our 280p price target (71% upside)"
